RNA Sequencing in B-Cell Lymphomas

Methods Mol Biol. 2019:1956:283-303. doi: 10.1007/978-1-4939-9151-8_13.

Abstract

High-throughput mRNA sequencing (RNA-Seq) provides both qualitative and quantitative evaluation of the transcriptome. This method uses complementary DNA (cDNA) to generate several millions of short sequence reads that are aligned to a reference genome allowing the comprehensive characterization of the transcripts in a cell. RNA-Seq has a wide variety of applications which lead to a pervasive adoption of this method well beyond the genomics community and a deployment of this technique as a standard part of the toolkit applied in life sciences. This chapter describes a protocol to perform mRNA sequencing using the Illumina NextSeq or MiSeq platforms, presents sequencing data quality metrics, and outlines a bioinformatic pipeline for sequence alignment, digital gene expression, identification of gene fusions, detection of transcript isoforms, description and annotation of genetic variants, and de novo immunoglobulin gene assembly.

Keywords: B cell; B-cell lymphoma; Gene expression; High-throughput sequencing; Immunoglobulin genes; Mutation; RNA-Seq; Transcriptome; VDJ.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing
  • Gene Expression Profiling / methods
  • Gene Fusion
  • Genes, Immunoglobulin
  • Genomics / methods*
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • Lymphoma, B-Cell / genetics*
  • Mutation
  • Polymorphism, Single Nucleotide
  • RNA, Messenger / genetics*
  • Sequence Analysis, RNA / methods*
  • Software
  • Transcriptome

Substances

  • RNA, Messenger